RVMD

insider transactions

Revolution Medicines, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 30d

-126.8K

0 buy · 126.8K sell

Net value · 30d

-$20.1M

$0 in · $20.1M out

Sentiment · 30d

Net selling

0% buying · 100% selling

Open-market trades · 30d

0 buy · 126.8K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Exercise·M
Jun 17, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$0

25.7K sh

Own +29%
Exercise·M
Jun 17, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$0

3.3K sh

Own +5%
Exercise·M
Jun 17, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$0

573 sh

Own +1%
Sell·S
Jun 17, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$4.7M

29.6K sh · $160.12

Own -16%
Exercise·M
Jun 17, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$681.7K

25.7K sh · $26.50

Own +16%
Exercise·M
Jun 17, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$98.4K

3.3K sh · $29.80

Own +2%
Exercise·M
Jun 17, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$23.3K

573 sh · $40.74

Own +0%
Sell·S
Jun 16, 26

Anthony Mancini

Chief Global Commercializatio…

$720.5K

4.6K sh · $156.12

Own -8%
Sell·S
Jun 16, 26

Stephen Michael Kelsey KEY

President, Research and Devel… · 10b5-1

$651.8K

4.2K sh · $156.12

Own -1%
Sell·S
Jun 16, 26

Mark A Goldsmith KEY

President and Chief Executive… · 10b5-1

$1.6M

10.0K sh · $156.12

Own -4%
Sell·S
Jun 16, 26

Jeff Cislini

General Counsel · 10b5-1

$336.7K

2.2K sh · $156.12

Own -4%
Sell·S
Jun 16, 26

Jack Anders KEY

Chief Financial Officer · 10b5-1

$425.0K

2.7K sh · $156.12

Own -2%
Exercise·M
Jun 15, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$0

44.9K sh

Own +149%
Exercise·M
Jun 15, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$0

15.5K sh

Own +26%
Sell·S
Jun 15, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$9.7M

60.4K sh · $160.17

Own -28%
Exercise·M
Jun 15, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$1.3M

44.9K sh · $29.80

Own +26%
Exercise·M
Jun 15, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$633.3K

15.5K sh · $40.74

Own +10%
Exercise·M
Jun 11, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$0

8.9K sh

Own +11%
Exercise·M
Jun 11, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$0

1.1K sh

Own New
Sell·S
Jun 11, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$30.0K

200 sh · $150.17

Own -0%
Sell·S
Jun 11, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$688.4K

4.6K sh · $149.64

Own -3%
Sell·S
Jun 11, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$267.7K

1.8K sh · $148.72

Own -1%
Sell·S
Jun 11, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$73.6K

500 sh · $147.27

Own -0%
Sell·S
Jun 11, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$102.2K

700 sh · $146.04

Own -0%
Sell·S
Jun 11, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$128.5K

885 sh · $145.15

Own -1%
Sell·S
Jun 11, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$189.7K

1.3K sh · $144.28

Own -1%
Exercise·M
Jun 11, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$362.8K

8.9K sh · $40.74

Own +6%
Exercise·M
Jun 11, 26

Margaret A Horn

Chief Operating Officer · 10b5-1

$46.4K

1.1K sh · $42.45

Own +1%
Exercise·M
May 26, 26

Anthony Mancini

Chief Global Commercializatio… · 10b5-1

$0

3.1K sh

Own +3%
Sell·S
May 26, 26

Anthony Mancini

Chief Global Commercializatio… · 10b5-1

$65.2K

421 sh · $154.82

Own -1%
Sell·S
May 26, 26

Anthony Mancini

Chief Global Commercializatio… · 10b5-1

$308.1K

2.0K sh · $154.06

Own -4%
Sell·S
May 26, 26

Anthony Mancini

Chief Global Commercializatio… · 10b5-1

$107.3K

700 sh · $153.30

Own -1%
Exercise·M
May 26, 26

Anthony Mancini

Chief Global Commercializatio… · 10b5-1

$104.9K

3.1K sh · $33.62

Own +6%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 17, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Exercise M	25.7K	+29%	—	$0
Jun 17, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Exercise M	3.3K	+5%	—	$0
Jun 17, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Exercise M	573	+1%	—	$0
Jun 17, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Sell S	29.6K	-16%	$160.12	$4.7M
Jun 17, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Exercise M	25.7K	+16%	$26.50	$681.7K
Jun 17, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Exercise M	3.3K	+2%	$29.80	$98.4K
Jun 17, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Exercise M	573	+0%	$40.74	$23.3K
Jun 16, 2026	Anthony Mancini	Chief Global Commercialization Officer	Sell S	4.6K	-8%	$156.12	$720.5K
Jun 16, 2026	Stephen Michael Kelsey KEY 10b5-1	President, Research and Development	Sell S	4.2K	-1%	$156.12	$651.8K
Jun 16, 2026	Mark A Goldsmith KEY 10b5-1	President and Chief Executive Officer	Sell S	10.0K	-4%	$156.12	$1.6M
Jun 16, 2026	Jeff Cislini 10b5-1	General Counsel	Sell S	2.2K	-4%	$156.12	$336.7K
Jun 16, 2026	Jack Anders KEY 10b5-1	Chief Financial Officer	Sell S	2.7K	-2%	$156.12	$425.0K
Jun 15, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Exercise M	44.9K	+149%	—	$0
Jun 15, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Exercise M	15.5K	+26%	—	$0
Jun 15, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Sell S	60.4K	-28%	$160.17	$9.7M
Jun 15, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Exercise M	44.9K	+26%	$29.80	$1.3M
Jun 15, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Exercise M	15.5K	+10%	$40.74	$633.3K
Jun 11, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Exercise M	8.9K	+11%	—	$0
Jun 11, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Exercise M	1.1K	New	—	$0
Jun 11, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Sell S	200	-0%	$150.17	$30.0K
Jun 11, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Sell S	4.6K	-3%	$149.64	$688.4K
Jun 11, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Sell S	1.8K	-1%	$148.72	$267.7K
Jun 11, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Sell S	500	-0%	$147.27	$73.6K
Jun 11, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Sell S	700	-0%	$146.04	$102.2K
Jun 11, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Sell S	885	-1%	$145.15	$128.5K
Jun 11, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Sell S	1.3K	-1%	$144.28	$189.7K
Jun 11, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Exercise M	8.9K	+6%	$40.74	$362.8K
Jun 11, 2026	Margaret A Horn 10b5-1	Chief Operating Officer	Exercise M	1.1K	+1%	$42.45	$46.4K
May 26, 2026	Anthony Mancini 10b5-1	Chief Global Commercialization Officer	Exercise M	3.1K	+3%	—	$0
May 26, 2026	Anthony Mancini 10b5-1	Chief Global Commercialization Officer	Sell S	421	-1%	$154.82	$65.2K
May 26, 2026	Anthony Mancini 10b5-1	Chief Global Commercialization Officer	Sell S	2.0K	-4%	$154.06	$308.1K
May 26, 2026	Anthony Mancini 10b5-1	Chief Global Commercialization Officer	Sell S	700	-1%	$153.30	$107.3K
May 26, 2026	Anthony Mancini 10b5-1	Chief Global Commercialization Officer	Exercise M	3.1K	+6%	$33.62	$104.9K

About RVMD insider trading

This page tracks insider transactions for Revolution Medicines, Inc. (RVMD) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.